Lumecca uses a powerful application of intense pulsed light (IPL) to treat pigmentated and vascular lesions and creates tissue heating which helps reduce inflammation in the periorbital region.
Inflammation is a contributing factor to Meibomian Gland Disorder (MGD). It causes vascular growth to occur in the tissue surrounding the meibomian glands disrupting their function. This in turn causes more inflammation and becomes a chronic, cyclical condition.
The wavelength of light used in IPL treatments is absorbed by the blood vessels causing coagulation and destroying them. The destruction of these vessels has allowed a rejuvenation of the architecture of the glands.
Those who suffer from rosacea and autoimmune disorders that increase inflammation within the body are often found to be affected by MGD. IPL has long been used to treat vascular lesions attributed to rosacea and many sufferers also experience dry, irritated eyes and eyelids. Ocular Rosacea symptoms often precede the skin symptoms, and your Optometrist may communicate with a General Practitioner if they believe additional testing may be to the patient's benefit.
